https://www.indianpharmapost.com/shukra-pharmaceuticals-receives-loa-from-rmscl-173202025-06-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/european-commission-approves-eylea-8-mg-with-extended-6-month-treatment-interval-for-namd-and-visual-impairment-due-to-dme-173212025-06-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-removal-of-rems-programs-within-bristol-myers-squibbs-cell-therapy-labels-173222025-06-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/ema-starts-review-of-sodium-oxybate-in-alcohol-dependence-173232025-06-28T00:00:00+05:30always0.9